172025-03

Restructuring and Breakthroughs: “New CMS” Starts a “New Journey” of Innovation丨CMS(867.HK)2024 Annual Performance Report in One Picture

IND Approval: CMS’s Self-developed Innovative Drug Cardiac Myosin Inhibitor CMS-D003 is Approved for Drug Clinical Trials

2025-03-12

China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that innovative drug CMS-D003 capsules (“CMS-D003”) self-developed by the Group has been granted approval for drug clinical trials by National Medical Products Administration of the People’s Republic of China (“NMPA”) on 11 March 2025. The approval was obtained on 12 March 2025. The NMPA grants the Group consent to conduct a clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of CMS-D003 in both healthy adults and adult patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in China.   CMS-D003 CMS-D003 is a small molecule cardiac myosin inhibitor, which is a targeted therapy for hypertrophic cardiomyopathy. By targeting inhibition of cardiac myosin adenosine triphosphate (ATP) enzymes, it inhibits myosin-actin interactions, reduces myofilament sliding, inhibits myocardial over-contraction, and improves diastolic dysfunction of the heart, thereby alleviating the patient’s clinical symptoms[1]. CMS-D003 demonstrates a short half-life, minimal risk for drug […]

China Medical System is Included in the S&P Global Sustainability Yearbook 2025

2025-02-13

In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited (“CMS” or the “Group”) has been included in the S&P Global Sustainability Yearbook 2025 (the “Yearbook 2025”). This marks the Group’s first inclusion in the global edition of S&P Global Sustainability Yearbook (the “Yearbook”), following the S&P Global Sustainability Yearbook (China Edition) inclusion for consecutive two years.   Source: S&P Global   Since its launch in 2008, the Yearbook’s professionalism and authority have been highly recognized by global ESG investors and other stakeholders. The Yearbook aims to identify outstanding companies in sustainable development from each industry. 7,690 companies across 62 industries were assessed, while only 780 stood out and were included in the Yearbook 2025. The inclusion in the Yearbook 2025 represents a high recognition of sustainable development practices of CMS.   CMS has been actively responding […]
China Medical System is Included in the S&P Global Sustainability Yearbook 2025

China Medical System is Included in the S&P Global Sustainability Yearbook 2025

2025-02-13

In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited (“CMS” or the “Group”) has been included in the S&P Global Sustainability Yearbook 2025 (the “Yearbook 2025”). This marks the Group’s first inclusion in the global edition of S&P Global Sustainability Yearbook (the “Yearbook”), following the S&P Global Sustainability Yearbook (China Edition) inclusion for consecutive two years.   Source: S&P Global   Since its launch in 2008, the Yearbook’s professionalism and authority have been highly recognized by global ESG investors and other stakeholders. The Yearbook aims to identify outstanding companies in sustainable development from each industry. 7,690 companies across 62 industries were assessed, while only 780 stood out and were included in the Yearbook 2025. The inclusion in the Yearbook 2025 represents a high recognition of sustainable development practices of CMS.   CMS has been actively responding […]

CMS Donated About RMB2.5 Million Worth of Special Fund and Supplies to Aid the Earthquake-stricken Area in Shigatse, Tibet

2025-01-13

On 7 January 2025, a magnitude 6.8 earthquake, which struck at a depth of 10 km, hit Tingri County, Shigatse City in Tibet, causing heavy casualties and house damages. Caring about the disaster, China Medical System Holdings Limited (“CMS”) has made proactive disaster relief efforts through its wholly-owned subsidiary, Tibet Kangzhe Pharmaceutical Development Co., Ltd. On January 9th, it donated relief supplies worth nearly RMB 0.5 million to the earthquake-stricken area through Tibet Development Philanthropic Foundation, including disinfectant, military coats, cotton quilts, and cotton jackets, etc. Moreover, on January 13th, it donated a special fund of RMB2 million to Tibet Charity Federation for post-disaster resettlement and reconstruction, to further help the disaster area to overcome the difficulties sooner.   Join hands to fight the disaster, and pray for peace and safety. CMS wishes the earthquake-stricken area in Shigatse, Tibet rebuild their homes as earlier as possible.  
China Medical System Included in the “Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness” for Three Consecutive Years, with New Honor of the “Top 10 Low-Carbon Pioneers”

China Medical System Included in the “Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness” for Three Consecutive Years, with New Honor of the “Top 10 Low-Carbon Pioneers”

2024-10-21

Recently, Healthcare Executive (“E药经理人”), in collaboration with a leading independent corporate social responsibility consulting agency in China, released the results of 2024 “Chinese Pharmaceutical Listed Companies ESG Competitiveness” series ranking. The ranking aims to recognize Chinese pharmaceutical companies that serve as benchmarks in various aspects of ESG management. By virtue of its continuous efforts in sustainable development and low-carbon initiatives, China Medical System (“CMS” or the “Group”) has been selected into the “Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness (Mid-cap Stocks)” ranking for three consecutive years, and has also been included in the inaugural “Top 10 Low-Carbon Pioneers of Chinese Pharmaceutical Listed Companies” ranking.     As an active practitioner of the sustainable development concept, CMS steadily responds to the United Nations Sustainable Development Goals, and promotes the deep integration of ESG governance with its macro strategies and business operations. With adherence to high standards of business ethics in its operations, the Group has established a scientific and effective risk identification […]

China Medical System Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG “AA” Rating

2024-07-16

In July 2024, China Medical System Holdings Limited (“CMS” or the “Group”) has once again been recognized for its outstanding performance and continuous progress in sustainable development. CMS was reincluded in the 2024 Sustainability Yearbook (China Edition) issued by S&P Global, a global-leading corporate sustainability assessment institution, and maintained its “AA” rating in the updated MSCI (Morgan Stanley Capital International) ESG Rating Report.   Re-including in S&P Global’s Sustainability Yearbook (China Edition) The S&P Global’s 2024 Sustainability Yearbook (China Edition) has been released. With an CSA score of 51 that surpassing 91% global peers in the industry, CMS stood out among more than 1,700 evaluated Chinese companies to be reincluded in the China Yearbook, becoming one of the five selected companies in the pharmaceutical industry. Source: S&P Global Receiving “AA” once again in MSCI ESG Rating In July, MSCI has released the latest ESG rating report for CMS. The Group […]
CMS Corporate Responsibility | Supporting the Implementation of “Canteen for Elderly” and “Public Library” Public Welfare Programs

CMS Corporate Responsibility | Supporting the Implementation of “Canteen for Elderly” and “Public Library” Public Welfare Programs

2024-06-25

On June 21, 2024, China Medical System Holdings Limited (“CMS”) was invited to attend the launching ceremony of the “Canteen for Elderly”, a digital meal delivery service project for elderly under the Public Welfare Program named “Hundreds, Thousands and Ten-Thousands Project (百千万工程)” . The ceremony was held in Lianping of Heyuan City, Guangdong Province.   CMS responds actively to the “Hundreds, Thousands and Ten-Thousand Project”. With assistance to accelerate the progress of the “Canteen for Elderly” project in Lianping, CMS also participated in the construction of the “Public Library” project to promote the livelihood projects implementation and benefit local population.   Canteen for Elderly Elderly meal delivery service is a common livelihood need of elderly people and their families. By donating through the Nanshan Charity Association，CMS participated in the construction of the “Canteen for Elderly in Lianping” project to provide the elderly with warm meals, and effectively improve their quality […]

CMS Charity | Protecting Exceptional Children, Creating a Better Future

2024-06-04

China Medical System Holdings Limited (“CMS”) persists in showing deep concern for exceptional children and has supported the sustainable development of rehabilitation centers through donations during the past two years. Meanwhile, we have witnessed that many exceptional children successfully integrated into regular schools and received compulsory education with the help of rehabilitation training, laying a solid foundation for their future integration into society and healthy growth.   With Children’s Day approaching, CMS again made donations to Shenzhen Nanshan Star Exceptional Children Rehabilitation Center and Shenzhen Nanshan Exceptional Children Care Center through Charity Association of Shenzhen Nanshan. The donation will be directly used for the procurement and renewal of teaching tools and toys in both centers, enhancing the children’s sense of gain, happiness, and security, as well as providing supports for creating good education atmosphere, encouraging outstanding teachers, and improving teaching quality.     At yesterday’s event, representatives of CMS interacted […]
China Medical System Won the “2023 Cailian Press Zhiyuan Award – Pioneer in Corporate Governance”

China Medical System Won the “2023 Cailian Press Zhiyuan Award – Pioneer in Corporate Governance”

2023-12-27

Recently, the fourth annual Environmental, Social, and Governance (ESG) Forum and Awards Ceremony hosted by Cailian Press ended successfully. China Medical System (“CMS”), with its long-term efforts and outstanding performance in the ESG field, was honored with the “2023 Cailian Press Zhiyuan Award – Pioneer in Corporate Governance.”   The Cailian Press Zhiyuan Award aims to select representative companies that have business value and social influence in the ESG field and have contributed to the sustainable development. Specifically, the “Pioneer in Corporate Governance” award evaluates the comprehensive performances in corporate governance and selects companies with leading practices in ESG strategy, governance, profitability, competitiveness, and related honors.   Upholding the ESG vision of becoming a world-leading sustainable pharmaceutical enterprise, CMS is dedicated to integrating sustainable development concepts into its overall strategy and daily operation. CMS has established a scientific and effective governance structure with clear responsibilities, and continuously promotes stakeholder engagement to optimize its internal […]

A Common Will is Strong as the Bulwarks, Watching and Helping Each Other | China Medical System supported earthquake relief work in Gansu and Qinghai

2023-12-25

At 23:59 on December 18th, a M6.2 earthquake with a depth of 10 kilometers occurred in Jishishan County, Linxia Prefecture, Gansu Province. The earthquake affected 22 villages and towns in Qinghai Province within a range of 50 kilometers from the epicenter, causing casualties and property damage in many areas of Gansu and Qinghai. The disaster in this cold winter is touching the hearts of the whole nation.       Merciless disaster, the world is love. The local governments and public welfare organizations attach great importance to this earthquake and provide necessary assistance and support to residents in the disaster area.   CMS actively and rapidly responded to support the rescue work in the earthquake-stricken areas. After understanding the needs of the disaster area at the first time, CMS urgently purchased a batch of emergency relief materials, including Halal meals, cold-proof clothing, heating equipment, sanitary supplies, etc. CMS rushed to the rescue of Gansu and Qinghai with actual […]
China Medical System Donated RMB 1 million for Floods Control and Disaster Relief of Beijing, Tianjin, Hebei and Other Areas

China Medical System Donated RMB 1 million for Floods Control and Disaster Relief of Beijing, Tianjin, Hebei and Other Areas

2023-08-04

Recently, Typhoon Doksuri has caused extreme rainfall in Beijing, Tianjin, Hebei, and other areas, leading to severe floods and geological disasters with casualties and significant property losses. China Medical System Holdings Ltd(“CMS”) quickly responded and made donation of RMB 1 million to the China Charity Federation on August 4th, to support emergency rescue and post-disaster reconstruction in severely affected areas of Beijing, Tianjin and Hebei, etc. At the same time, we pay the highest respects to all the heroes who are participating in the front-line disaster relief efforts! Let us unite and work together to tide over the difficulties. May the affected areas could be recovered as soon as possible.

China Medical System received MSCI-ESG “AA” rating again, leading the industry in ESG management

2023-07-28

Recently, MSCI (Morgan Stanley Capital International), the world’s largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited (“CMS” or the “Group”), who achieved an “AA” rating and surpassed 75% of global peers with leading ESG management practices. MSCI is one of the most widely used, influential, and referenced rating companies in the global market. Based on a scientifically rigorous evaluation system, it evaluates companies’ risk control performance and sustainable development potential comprehensively from various aspects such as environment, human capital, health accessibility, product safety and quality, and corporate governance. MSCI-ESG rating results have been regarded by global investors as an important non-financial basis for investment decision-making. Being back to the “AA” rating, reflects the full recognition of the Group’s ESG management practices by the international authoritative rating company. The Group deeply integrates the concept of sustainable development into its operations […]
China Medical System Included in the First “Sustainability Yearbook (China)” of S&P Global

China Medical System Included in the First “Sustainability Yearbook (China)” of S&P Global

2023-06-29

Recently, S&P Global, the world’s leading corporate sustainability assessment institution, has officially released the first “Sustainability Yearbook 2023 (China)”. China Medical System Holdings Limited (“CMS” or the “Group”), standing out from many outstanding companies, was successfully included in this Yearbook. Previously, S&P Global updated CMS’s Sustainability Score to 53, surpassing 92% of the global peers participating in this evaluation, and it is significantly ahead of the industry average. S&P Global has published global versions of the “Sustainability Yearbook” for 16 consecutive years, and has received extensive attention and recognition. This year, S&P Global published the “Sustainability Yearbook (China)” for the first time, aiming to identify and recognize Chinese companies that have great sustainable development performance in different industries. Nearly 1600 Chinese companies from 60 industries were included in the selection pool of the yearbook, but only companies that scored within the top 15% of their industries and achieved a S&P […]

China Medical System Proactively Supported Pandemic Prevention and Control in Tibet

2022-08-26

In August 2022, the COVID-19 pandemic struck Tibet Autonomous Region and the pandemic situation was complex. China Medical System Holdings Limited (“CMS”) has paid close attention to the pandemic condition, and in order to support the pandemic prevention and control, its subsidiary Tibet Kangzhe Pharmaceutical Development Co. (“Tibet Kangzhe”) has donated several kinds of epidemic prevention materials to the local government, schools and communities, including medical protective clothing, N95 masks, medical gloves and ethanol disinfectant, etc., while quickly organizing its staff to join the volunteer groups to support the transport of anti-epidemic supplies, nucleic acid testing and pandemic prevention propaganda. The Group will continue to pay close attention to the pandemic condition and actively participate in the pandemic prevention and control works, so as to fulfill our mission and responsibility with concrete actions. Under the effective control of the Tibetan government, we look forward to a victory against the pandemic in Tibet.